While neutralizing antibodies can block ACE2:RBD interaction and protect against initial infection, the non-Spike protein cross-reactive memory T cell immunity is essential for protection from severe disease and for long-term prevention against infection; and, as such, T cell immunity should be recognized as a measure for long-term vaccine success [72–79]. The gene discussed is ACE2; the disease is infection.